目的：为进一步提高国家药品标准物质的供应保障能力、提升服务质量和服务水平，更好地支撑药品监管需求和行业发展。方法：通过研究中国食品药品检定研究院标准物质供应部门2022年接收的标准物质供应申请资料，梳理供应流程的各环节要素，分析供货周期的影响因素。结果：通过分析标准物质的供应流程，可为用户顺利订购提供指导，也为提高订单处理的工作效率提供参考。结论：通过梳理并优化标准物质供应流程、简化工作程序，可以方便用户自主订购、提高订单处理效率、节省人力与时间成本，实现用户与供应机构双赢，并有助于把好饮食用药安全关。
Objective: To further improve the supply guarantee ability of the national drug reference standards, improve service quality and service level, so as to better meet the drug regulatory requirements and ensure the development of the industry. Methods: By studying the application materials for reference standards received by the reference standard supply department of the NIFDC in 2022, the elements in each link of the supply process were sorted out and the factors aff ecting the supply cycle were analyzed. Results: By studying the supply process of reference standards, it could provide guidance for users to order smoothly and also provide references for improving the effi ciency of order processing. Conclusion: By sorting out and optimizing the supply process of reference standards and simplifying the working procedures, it can facilitate users to order independently, improve the effi ciency of order processing, save labor and time costs, achieve a win-win situation between users and the supply organization, and help to ensure the safety of food and medicine.
[1] 国家药典委员会.中华人民共和国药典:四部[S].2020:33.
[2] 曹丽梅,马双成,马玲云,等.中检所药品、医疗器械标准物质管理新模式-从分散多头管理走向集中统一管理[J].药物分析杂志,2010,30(10):1993-1994.
[3] 中央机构编制委员会办公室.中央编办复字[2010]282 关于中国药品生物制品检定所更名的批复[S].2010.
[4] 中国食品药品检定研究院.中国食品药品检定研究院(国家药品监督管理局医疗器械标准管理中心,中国药品检验总所)主要职责内设机构和人员编制规定[EB/OL].(2018-12-29)[2023-03-09].https://www.nifdc.org.cn//nifdc/jgshzh/zjyjsh/20181229110700423.html.
[5] 全国人民代表大会.中华人民共和国药品管理法[EB/OL].(2019-08-27)[2023-03-09].https://www.nmpa.gov.cn/xxgk/fgwj/flxzhfg/20190827083801685.html
[6] 陈亚飞,刘明理,赵宗阁,等.药品标准物质的管理与研制生产质量控制[J].中国药事,2018,32(11):1505-1510.
[7] 高志峰,肖新月,曹丽梅,等.国家药品标准物质一级直供的实施要点研究[J].新药述评与论坛,2021,30(1):13-16.
[8] 中国食品药品检定研究院.国家药品标准物质查询与订购平台[EB/OL].(2009-03-27)[2023-03-09].http://aoc.nifdc.org.cn/sell/login_w2.jsp.
[9] 曹丽梅,刘明理,赵宗阁,等.国家药品标准物质管理系统的建立及介绍[J].中国药事,2017,31(8):882-886.
[10] 曹丽梅,肖新月,王一平,等.定量标记免疫分析用国家标准品研制技术要求介绍[J].标记免疫分析与临床,2018,25(7):1074-1076.
[11] 谢晶鑫,刘明理,肖新月.对国家药品标准物质中涉及剧毒品种供应难题的探讨[J].中国药事,2021,35(10):1107-1109.
[12] 曹丽梅,刘明理,袁伟媛,等.国家药品标准物质在生物制品质量控制中的应用[J].中国生物制品学杂志,2019,32(9):1054-1056.
[13] 王雅君,王丽,赵宗阁.国家药品标准物质标签及其说明书管理的风险控制[J].中国药事,2019,33(4):399-401.
[14] 谢晶鑫,王青,刘明理,等.国家药品标准物质原料的风险管理及征集对策[J].中国医药工业杂志,2022,53(12):1814-1819.
[15] 胡康,曹丽梅,高志峰,等.销量预测算法在药品标准物质管理中的应用[J].中国药学杂志,2021,56(16):1336-1341.
